Results
71,123 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 22 | Costello Beth AnnEVP and CFO |  HIGHARTFORD INSURANCE GROUP, INC.Open-market sale · 10b5-1 plan | SELL | $4.29M 31.6K sh | Nov 4, 2026 |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 22 | Costello Beth AnnEVP and CFO | HIGHARTFORD INSURANCE GROUP, INC. Open-market sale · 10b5-1 plan | SELL | $4.29M 31.6K sh | Nov 4, 2026 |
| 22 | Swanson Luke RoyCHIEF TECHNOLOGY OFFICER |  IBTAIbotta, Inc.Open-market sale · 10b5-1 plan | SELL | $344K 6,893 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 22 | Flavin LisaSenior VP & CCO |  EMREMERSON ELECTRIC COTax withholding | F | $1.04M 6,206 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 22 | Atay OguzhanDirector, Chairman and CEO |  BLLNBillionToOne, Inc.Open-market sale · 10b5-1 plan | SELL | $624K 5,720 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 22 | Atay OguzhanDirector, Chairman and CEO | BLLNBillionToOne, Inc. Open-market sale · 10b5-1 plan | SELL | $419K 3,803 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 22 | Atay OguzhanDirector, Chairman and CEO | BLLNBillionToOne, Inc. Open-market sale · 10b5-1 plan | SELL | $267K 2,451 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 22 | Tsao DavidDirector, Chief Technology Officer | BLLNBillionToOne, Inc. Open-market sale · 10b5-1 plan | SELL | $266K 2,450 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 22 | Sing George LDirector |  REGNREGENERON PHARMACEUTICALS, INC.Option exercise | M | $2.83M 7,439 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 21 | Cook Melanie K.Director |  MBUUMALIBU BOATS, INC.Grant or award | A | — 4,562 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 21 | Pershing John EChief Human Resources Officer |  BURLBurlington Stores, Inc.Grant or award | A | — 2,094 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 21 | Krishnan Ram R.Executive Vice Pres & COO | EMREMERSON ELECTRIC CO Grant or award | A | — 60.4K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 21 | Nonko EugeneDirector |  MAXMediaAlpha, Inc.Open-market sale · 10b5-1 plan | SELL | $1.15M 78.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 21 | Schneider Andrea LPres & CEO Horizon Airlines |  ALKALASKA AIR GROUP, INC.Option exercise | M | — 378 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 21 | Boone Jandeen MEVP, GC & Secretary |  ECLECOLAB INC.Option exercise | M | — 1,769 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 21 | Saadi Ryan H.Director, Chief Executive Officer, 10% Owner |  TVGNTevogen Inc.Grant or award | A | — 50.00M sh | Nov 4, 2026 traded Nov 2, 2026 |
| 21 |  Silbermann BenjaminDirector, 10% Owner |  PINSPINTEREST, INC.Open-market sale · 10b5-1 plan | SELL | $934K 46.9K sh | Nov 4, 2026 traded Nov 3, 2026 |
| 21 | Linnane Robert13D Group Member |  NGVCNatural Grocers by Vitamin Cottage, Inc.Option exercise | M | — 2,000 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 21 | George Jennifer LSEVP and COO |  CBFVCB Financial Services, Inc.Open-market sale | SELL | $11K 283 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 21 | Davidson MattDirector, President and CEO |  AZRAzora Therapeutics, Inc. (DE)Derivative conversion | C | — 101.3K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 21 | Davidson MattDirector, President and CEO | AZRAzora Therapeutics, Inc. (DE) Derivative conversion | C | — 525 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 21 | Silbermann BenjaminDirector, 10% Owner | PINSPINTEREST, INC. Open-market sale · 10b5-1 plan | SELL | $984K 46.9K sh | Nov 4, 2026 traded Nov 4, 2026 |
| 21 | Gernetzke JamesChief Financial Officer |  EXODExodus Movement, Inc.Open-market sale | SELL | $28K 5,781 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 21 | Linnane Robert13D Group Member | NGVCNatural Grocers by Vitamin Cottage, Inc. Option exercise | M | — 2,000 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 21 | Anderson RaymondDirector |  MNPRMonopar TherapeuticsOpen-market sale · 10b5-1 plan | SELL | $105K 1,502 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 21 | Isely Raquel M.13D Group Member | NGVCNatural Grocers by Vitamin Cottage, Inc. Option exercise | M | — 4,000 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 21 | Fang AndyDirector |  DASHDoorDash, Inc.Open-market sale · 10b5-1 plan | SELL | $906K 5,000 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 21 | Nonko EugeneDirector | MAXMediaAlpha, Inc. Open-market sale · 10b5-1 plan | SELL | $1.62M 109.4K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 21 | Berry Jason MEVP & Chief Operating Officer | ALKALASKA AIR GROUP, INC. Option exercise | M | — 663 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 21 | Yi StevenDirector, See Remarks | MAXMediaAlpha, Inc. Open-market sale · 10b5-1 plan | SELL | $2.05M 138.8K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 21 | Kolstad Gary ADirector |  RESRPC INCGrant or award | A | — 15.3K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 21 | Maetzold Derek JDirector, Pres. & Chief Exec. Officer |  CSTLCASTLE BIOSCIENCES INCOpen-market sale · 10b5-1 plan | SELL | $272K 7,555 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 21 | Woelkers Paul C.Director |  FDBCFIDELITY D & D BANCORP INCOpen-market sale | SELL | $35K 500 sh | Nov 4, 2026 traded Nov 4, 2026 |
| 21 | DM Individual Aggregator, LLC10% Owner |  BROSDutch Bros Inc.Open-market sale · 10b5-1 plan | SELL | $134K 2,986 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 21 | Hecht BethSee Remarks |  XERSXeris Biopharma Holdings, Inc.Open-market sale · 10b5-1 plan | SELL | $256K 25.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 21 | George Jennifer LSEVP and COO | CBFVCB Financial Services, Inc. Open-market sale | SELL | $1,212 30 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 21 | Sordello Steven JDirector |  COMPCompass, Inc.Option exercise | M | — 2,419 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 21 | Lewis Stephen EDirector | RESRPC INC Grant or award | A | — 15.3K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 21 | Davidson MattDirector, President and CEO | AZRAzora Therapeutics, Inc. (DE) Derivative conversion | C | — 525.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 21 | Saiki JulieChief Strategy Officer | AZRAzora Therapeutics, Inc. (DE) Derivative conversion | C | — 626 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 21 | Saiki JulieChief Strategy Officer | AZRAzora Therapeutics, Inc. (DE) Derivative conversion | C | — 626.3K sh | Nov 4, 2026 traded Nov 2, 2026 |